VivoSeq
Other

Amnesia

8

Pipeline Programs↗

1

Active Trials↗

6

Companies Involved↗

Amnesia is an early-stage landscape with 8 programs across 6 companies. The most active players are Fresenius Kabi Oncology Ltd., Pfizer, COMPASS Pathways. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

0/100

Mech. Concentration

40/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

F

Fresenius Kabi Oncology Ltd.

1 program

Phase 1Pfizer logo

Pfizer

1 program

Phase 1COMPASS Pathways logo

COMPASS Pathways

1 program

Phase 1Boehringer Ingelheim logo

Boehringer Ingelheim

1 program

Phase 1AstraZeneca logo

AstraZeneca

1 program

ApprovedSinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

4

clinical trials

Completed3 · 75%
Active, not recruiting1 · 25%

Clinical Trials

Trial Activity

Does Midazolam Cause Effective Anterograde Amnesia in Orthopedic Surgeries?
Completed·UUniversity of Jordan·N/A·NCT04232150·116 enrolled
Effect of Affective Content on Drug Induced Amnesia of Episodic Memory
Completed·MMemorial Sloan Kettering Cancer Center·Phase 1·NCT00142493·79 enrolled
Investigation of Immune Amnesia Following Measles Infection in Select African Regions
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT06153979·256 enrolled
Dose Response Effect of Nitrous Oxide on Amnesia in Healthy Children
Completed·SState University of New York at Buffalo·Preclinical·NCT02050152·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)